NCT03344068View on ClinicalTrials.gov

Early and Whole Course Nutritional Support by Nutren® Optimum During IMRT for Nasopharyngeal Carcinoma

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

408

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

March 31, 2021

Conditions
Nasopharyngeal CarcinomaNutritional Support
Interventions
RADIATION

Radiotherapy

Intensity Modulated Radiation Therapy, Dose: GTVnx 6810cGy/30Fr, GTVnd 6400-6600cGy/30Fr, CTV1 6000cGy, CTV2 5400cGy.

DRUG

Chemotherapy

Nedaplatin 80mg/m2 d1+5-fluouracil 500mg/m2 d2-5, every 3 weeks; a total of 2-3 cycles.

DIETARY_SUPPLEMENT

Nutren® Optimum

Nutren® Optimum, 7 scoops each time, three times a day, at begin of radiotherapy

Trial Locations (1)

510060

Department of Radiation Oncology, Sun Yat-Sen University Cancer Center, Guangzhou

Sponsors

Collaborators (1)

Nestle Health Science
All Listed Sponsors
collaborator

Nestle Health Science

INDUSTRY

lead

Sun Yat-sen University

OTHER